1932

Abstract

Recent advances in a variety of areas of research, particularly in genetics and in transgenic (Tg)/gene targeting approaches, have had a substantial impact on our understanding of Alzheimer's disease (AD) and related disorders. After briefly reviewing the progress that has been made in diagnostic assessments of patients with senile dementia and in investigations of the neuropathology of AD, we discuss some of the genes/proteins that are causative or risk factors for this disease, including those encoding amyloid precursor protein, presenilin 1 and 2, and apolipoprotein E. In addition, we comment on several potential new candidate loci/genes. Subsequently, we review selected recent reports of analyses of a variety of lines of Tg mice that show several neuropathological features of AD, including Aβ-amyloid deposits and dystrophic neurites. Finally, we discuss the several important issues in future investigations of Tg mice, with particular emphasis on the influences of genetic strains on phenotype, especially behavior, and strategies for making new models of neurodegenerative disorders. We believe that investigations of these Tg models will () enhance understanding of the relationships between impaired performance on memory tasks and the pathological/biochemical abnormalities in brain, () help to clarify pathogenic mechanisms in vivo, () lead to identification of new therapeutic targets, and () allow testing of new treatment strategies first in mice and then, if successful, in humans with AD.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.genet.32.1.461
1998-12-01
2024-04-16
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.genet.32.1.461
Loading
  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error